Dodge & Cox Bought Shares of 8,079 Walgreens Boots Alliance Inc (WBA)

Dodge & Cox Bought Shares of 8,079 Walgreens Boots Alliance Inc (WBA)

Dodge & Cox acquired a new stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) during the fourth quarter, Holdings Channel reports. The firm acquired 8,079 shares of the pharmacy operator’s stock, valued at approximately $669,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Aristotle Capital Management LLC boosted its position in shares of Walgreens Boots Alliance by 2.2% in the fourth quarter. Aristotle Capital Management LLC now owns 3,471,692 shares of the pharmacy operator’s stock valued at $287,317,000 after buying an additional 74,281 shares during the last quarter. Norges Bank purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $649,813,000. Sowell Financial Services LLC purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $225,000. Putnam Investments LLC boosted its position in shares of Walgreens Boots Alliance by 24.5% in the fourth quarter. Putnam Investments LLC now owns 4,090,605 shares of the pharmacy operator’s stock valued at $338,539,000 after buying an additional 804,863 shares during the last quarter. Finally, Jarislowsky Fraser Ltd boosted its position in shares of Walgreens Boots Alliance by 0.7% in the fourth quarter. Jarislowsky Fraser Ltd now owns 2,244,953 shares of the pharmacy operator’s stock valued at $185,792,000 after buying an additional 15,829 shares during the last quarter. Institutional investors own 59.98% of the company’s stock.

Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at 83.05 on Friday. The company’s 50-day moving average is $85.06 and its 200 day moving average is $83.05. Walgreens Boots Alliance Inc has a 12 month low of $75.74 and a 12 month high of $88.00. The company has a market cap of $89.64 billion, a price-to-earnings ratio of 21.98 and a beta of 1.20.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, January 5th. The pharmacy operator reported $1.10 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.09 by $0.01. The company earned $28.50 billion during the quarter. Walgreens Boots Alliance had a return on equity of 16.76% and a net margin of 3.52%. Walgreens Boots Alliance’s quarterly revenue was down 1.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.03 earnings per share. Equities analysts forecast that Walgreens Boots Alliance Inc will post $5.00 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Friday, March 10th. Stockholders of record on Wednesday, February 15th were given a dividend of $0.375 per share. The ex-dividend date was Monday, February 13th. This represents a $1.50 annualized dividend and a dividend yield of 1.81%. Walgreens Boots Alliance’s payout ratio is currently 39.68%.

Several research analysts have commented on the stock. Jefferies Group LLC reiterated a “buy” rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a report on Friday. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday. Robert W. Baird reiterated an “outperform” rating and issued a $96.00 target price on shares of Walgreens Boots Alliance in a report on Monday, March 27th. Deutsche Bank AG reiterated a “buy” rating and issued a $92.00 target price on shares of Walgreens Boots Alliance in a report on Wednesday, March 22nd. Finally, Atlantic Securities upgraded shares of Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and set a $95.00 target price for the company in a report on Monday, February 6th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and eleven have issued a buy rating to the company’s stock. Walgreens Boots Alliance has a consensus rating of “Buy” and an average target price of $91.56.

In other Walgreens Boots Alliance news, Director Janice M. Babiak acquired 600 shares of the firm’s stock in a transaction that occurred on Thursday, February 2nd. The stock was acquired at an average cost of $80.68 per share, for a total transaction of $48,408.00. Following the transaction, the director now owns 600 shares of the company’s stock, valued at $48,408. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Ornella Barra acquired 124,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 7th. The stock was acquired at an average price of $80.93 per share, with a total value of $10,035,320.00. Following the completion of the transaction, the chief operating officer now directly owns 1,690,336 shares in the company, valued at approximately $136,798,892.48. The disclosure for this purchase can be found here. 13.50% of the stock is currently owned by insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Related posts

Leave a Comment